Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

Application of gene editing technology in behavioral medicine and its regulatory policy

[Progress of gene editing technologies and prospect in traditional Chinese medicine]

Gene Editing and Its Applications in Biomedicine

[The application of human genetic technology in the medical field urgently needs standardization]

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Development and application of CRISPR/Cas9 technologies in genomic editing.

Gene editing: from technologies to applications in research and beyond

The Development of Gene Editing Technology and Controversial Issues: A Discussion

The application of gene editing in treating cancer

Research Progress in Mitochondrial Gene Editing Technology.

Evolution and application of gene editing technology

Gene Editing in Pluripotent Stem Cells and Their Derived Organoids

The application and development of CRISPR Cas9

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Gene Editing Technology and Ethical Issues

Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

Gene editing technology and its research progress in China

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems